Tekedia Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Exin Therapeutics develops an AI-guided drug discovery platform that uses experimental mouse studies to identify neurological therapies, starting with epilepsies linked to autism and Parkinson's disease.
BiotechHealthtechSan Francisco, US
Gabriel Ocana Santero(CEO)inMarko Tvrdic(COO)inIvan Alex Priela Lazarte(Executive Officer, Director)inIvan Lazarte(Founder)
Co-investorsAlumni VenturesMULTIMODAL VENTURESY Combinator468 CapitalFounder CapitalOurCrowd+1 more
WinichFarms operates a technology-driven agribusiness platform that connects farmers directly with business buyers, handling pricing and supply chain logistics for food distribution.
AgTechB2B MarketplacesFintechFoodTech
Riches Attai(Co-Founder & CEO)inWinner Attai(Co-Founder & COO)Chichebem Jibunoh(Co-Founder & CTO)
Co-investorsAcasia VenturesCairo Angels Syndicate FundExpert DOJOFounders Factory AfricaPlug and Play VenturesSahel Capital+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.









